The value of bone marrow scintigraphy using 99mTc monoclonal antigranulocyte antibodies in complement to bone scintigraphy in detecting bone metastases from primary breast cancer

Verfasser / Beitragende:
[J. O. Prior, G. Barghouth, J. F. Delaloye, S. Leyvraz, A. Bischof Delaloye]
Ort, Verlag, Jahr:
2003
Enthalten in:
Nuclear Medicine Communications, 24/1(2003-01), 29-36
Format:
Artikel (online)
ID: 439420962